Quick Takeaways
- Cormorant Asset Management, LP filed SCHEDULE 13G/A for Bright Minds Biosciences Inc. Common Shares (DRUG).
- Disclosed ownership: 11%.
- Date of event: 31 Jan 2026.
Cormorant Asset Management, LP - 31 Jan 2026 SCHEDULE 13G/A Report for Bright Minds Biosciences Inc. Common Shares (DRUG)
- Filing Manager
- Cormorant Asset Management, LP
- Reporting Manager
- Cormorant Asset Management, LP
- Symbol
- DRUG
- Shares outstanding
- 9,736,498 shares
- Disclosed Ownership
- 1,059,331 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Feb 2026, 15:00:09 UTC
- Date of event
- 31 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Cormorant Asset Management, LP disclosed 11% ownership in Bright Minds Biosciences Inc. Common Shares (DRUG) on 31 Jan 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Feb 2026, 15:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 11% | 1,059,331 | 0 | 1,059,331 | /s/ Bihua Chen | Bihua Chen, Managing Member | |
| Bihua Chen | 11% | 1,059,331 | 0 | 1,059,331 | /s/ Bihua Chen | Bihua Chen |